O29 Pegylated Recombinant Domain I of β-2-Glycoprotein I, a Potential Therapeutic Agent for Anti-Phospholipid Syndrome, Fully Retains its Ability to Inhibit Binding of IGG or IGA Antibodies from Patients with Anti-Phospholipid Syndromeaps to β-2-Glycoprotein GPI in Vitro
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.